These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1878086)

  • 1. [Gleason's classification of prostatic adenocarcinomas].
    McNeal JE; Gleason DF
    Ann Pathol; 1991; 11(3):163-8. PubMed ID: 1878086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
    Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gleason's grading of prostatic cancer: a current perspective].
    Cheng L; Wang X; Zhu YL; Zhang JM; Lopez-Beltran A; Montironi R
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):577-80. PubMed ID: 22177238
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gleason's score in prostate adenocarcinoma and its application].
    Cao D
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):145-8. PubMed ID: 24842010
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gleason's score: update in 2008].
    Molinié V
    Ann Pathol; 2008 Oct; 28(5):350-3. PubMed ID: 19068389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with Gleason's histopathologic grading in prostatic cancer.
    Kramer SA; Spahr J; Brendler CB; Glenn JF; Paulson DF
    J Urol; 1980 Aug; 124(2):223-5. PubMed ID: 6995622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reproducibility of malignancy grading in prostatic cancers using the Gleason-Böckling system].
    Kiss F; Lakner G; Csellár M; Nagy P; Tóth A; Vittay G
    Orv Hetil; 1997 May; 138(19):1195-9. PubMed ID: 9235527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and pathological study of prostate cancer using Gleason's classification].
    Nemoto R; Uchida K; Kiriyama I; Koiso K; Harada M
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2325-30. PubMed ID: 3449581
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histological classification of prostatic cancer].
    Sakamoto A; Terado Y
    Nihon Rinsho; 1998 Aug; 56(8):1959-62. PubMed ID: 9750487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen fibers in human prostatic lesions: histochemistry and anisotropies.
    Taboga SR; Vidal Bde C
    J Submicrosc Cytol Pathol; 2003 Jan; 35(1):11-6. PubMed ID: 12762646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reproducibility and prognostic value of Gleason's and Gaeta's histological grades in prostatic carcinoma].
    Rousselet MC; Saint-André JP; Six P; Soret JY
    Ann Urol (Paris); 1986; 20(5):317-22. PubMed ID: 3777875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].
    Saint-André JP; Rousselet MC; Six P; Bertrand G; Soret JY
    Bull Cancer; 1985; 72(5):414-22. PubMed ID: 4074910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification, histological and cytological grading and assessment of regression grading in prostatic carcinomas. A recommendation of the Pathologic-Urological Task Force on Prostatic Carcinoma].
    Helpap B; Böcking A; Dhom G; Faul P; Kastendieck H; Leistenschneider W; Müller HA
    Pathologe; 1985 Jan; 6(1):3-7. PubMed ID: 3983085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathological anatomy of adenocarcinoma of the prostate in 1988].
    Desligneres S
    Ann Pathol; 1988; 8(2):91-105. PubMed ID: 3041984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer of the prostate: reclaiming Gleason's sum].
    Espuela Orgaz R; Nogueras Gimeno MA; Passas Martínez J; Ruiz Liso JM; Sanz Anquela M
    Actas Urol Esp; 1982; 6(6):317-22. PubMed ID: 7183177
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological aggressiveness evaluation in prostate carcinomas:immunohistochemical analysis of PCNA and p53 in a series of Gleason 6 (3+3) adenocarcinomas.
    Cappello F; Palma A; Martorana A; Rappa F; Cabibi D; Barresi E; Melloni D; Farina F; Aragona F
    Eur J Histochem; 2003; 47(2):129-32. PubMed ID: 12777208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic diagnosis and classification of prostate adenocarcinoma: biologic significance.
    Peters JM; Crissman JD
    Henry Ford Hosp Med J; 1989; 37(1):8-13. PubMed ID: 2670842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative assessment of the WHO and Gilson histological classifications of prostatic neoplasms (taking into account data of ploidy studies)].
    Gundorova LV; Avtandilov GG; Zakhmatov IuM; Varentsov GI; Borshch VIu
    Urologiia; 2003; (5):9-13. PubMed ID: 14658264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.